Quin is pioneering a new era of direct-to-consumer Virtual Care 2.0 for diabetes that doesn’t rely on human healthcare professionals. Unlike existing diabetes platforms, which add a digital veneer to already ineffective analogue healthcare models, Quin goes deep into the 24x7 needs of the individual living with the condition. Their groundbreaking personalization model empowers people to better manage on their own, when they’re away from their doctors and living their day-to-day life — where 99.9% of diabetes care actually happens. The first Quin app is a novel digital therapeutic for personalized independent self-management of type 1 diabetes. It regularly ranks in the top #1-3 most-downloaded diabetes apps in the App Store in the UK and Ireland. 96% of Quin users experience better health outcomes or wellbeing, or both. Early data shows a massive opportunity to improve time-in-range (a critical healthcare metric) by 10-20% for those starting at less than 70%.

ControlDTx provides a digital therapeutics service that provides online prevention and treatment for chronic illnesses such as high blood pressure, type 2 & prediabetes, dyslipidemia & elevated cholesterol, obesity and overweight conditions.

Using AI, we leverage and harness your knowledge, your experience and the data you input into Quin to surface the information you need at the right time, at a glance. Quin gives you information you can trust because it came from your experience.

Recommended by doctors and pharmacists, the RediCare ControlDTx programme enables you to easily lose weight, lower blood pressure, improve cholesterol and treat type 2 diabetes.